April 27, 2022
Multiplex Base Editing in Human Hematopoietic Stem and Progenitor Cells (HSPCs) Enables Efficient Removal of Multiple Surface Antigens in Acute Myeloid Leukemia (AML) Immunotherapy
CD33-CLL1 Treatment System, Platform
Presented by: Genome Engineering Team – Vor Bio
Keystone Symposia – 2022 – Poster Presentation 3001